{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:49:56Z","timestamp":1793749796353,"version":"4.6.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018731","name":"Jiangsu Hengrui Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018731","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chinese society of cardiology Foundation","award":["CSCF2019A01"],"award-info":[{"award-number":["CSCF2019A01"]}]}],"content-domain":{"domain":["jscai.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Society for Cardiovascular Angiography &amp; Interventions"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jscai.2025.103790","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T09:13:24Z","timestamp":1753953204000},"page":"103790","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of Pre-PCI Activated Clotting Time on Outcomes of Bivalirudin Versus Heparin During Primary PCI"],"prefix":"10.1016","volume":"4","author":[{"given":"Meili","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaohan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanzhe","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiancai","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jili","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haipeng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaling","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3416-8210","authenticated-orcid":false,"given":"Gregg W.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jscai.2025.103790_bib1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"issue":"20","key":"10.1016\/j.jscai.2025.103790_bib2","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1093\/eurheartj\/ehq277","article-title":"Guidelines on myocardial revascularization","volume":"31","author":"Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI)","year":"2010","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.jscai.2025.103790_bib3","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/CIRCULATIONAHA.106.612812","article-title":"Adverse impact of bleeding on prognosis in patients with acute coronary syndromes","volume":"114","author":"Eikelboom","year":"2006","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.jscai.2025.103790_bib4","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/jama.292.13.1555","article-title":"Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes","volume":"292","author":"Rao","year":"2004","journal-title":"JAMA"},{"issue":"21","key":"10.1016\/j.jscai.2025.103790_bib5","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1056\/NEJMoa0708191","article-title":"Bivalirudin during primary PCI in acute myocardial infarction","volume":"358","author":"Stone","year":"2008","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.jscai.2025.103790_bib6","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1093\/eurheartj\/ehp110","article-title":"Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial","volume":"30","author":"Mehran","year":"2009","journal-title":"Eur Heart J"},{"issue":"9665","key":"10.1016\/j.jscai.2025.103790_bib7","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0140-6736(09)60413-X","article-title":"Ischaemia versus bleeding: the art of clinical decision-making","volume":"373","author":"Stone","year":"2009","journal-title":"Lancet"},{"issue":"9151","key":"10.1016\/j.jscai.2025.103790_bib8","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0140-6736(98)07332-2","volume":"353","year":"1999","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jscai.2025.103790_bib9","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/CIR.0b013e3182742c84","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"127","author":"O\u2019Gara","year":"2013","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.jscai.2025.103790_bib10","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1161\/01.CIR.0000139868.53594.24","article-title":"Relationship between activated clotting time and ischemic or hemorrhagic complications: analysis of 4 recent randomized clinical trials of percutaneous coronary intervention","volume":"110","author":"Brener","year":"2004","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.jscai.2025.103790_bib11","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/01.CIR.103.7.961","article-title":"Defining the optimal activated clotting time during percutaneous coronary intervention: aggregate results from 6 randomized, controlled trials","volume":"103","author":"Chew","year":"2001","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jscai.2025.103790_bib12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0002-9149(03)00637-4","article-title":"Relation between the degree of procedural anticoagulation and complications after coronary stent implantation","volume":"92","author":"Ashby","year":"2003","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.jscai.2025.103790_bib13","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1161\/CIRCINTERVENTIONS.111.961912","article-title":"Bleeding risk comparing targeted low-dose heparin with bivalirudin in patients undergoing percutaneous coronary intervention: results from a propensity score-matched analysis of the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry","volume":"4","author":"Bangalore","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"issue":"3","key":"10.1016\/j.jscai.2025.103790_bib14","doi-asserted-by":"crossref","first-page":"V275","DOI":"10.1016\/S0049-3848(02)00093-2","article-title":"Direct thrombin inhibitors","volume":"106","author":"Weitz","year":"2002","journal-title":"Thromb Res"},{"issue":"24","key":"10.1016\/j.jscai.2025.103790_bib15","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","article-title":"2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"64","author":"Amsterdam","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"10.1016\/j.jscai.2025.103790_bib16","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","article-title":"2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"42","author":"Collet","year":"2021","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.jscai.2025.103790_bib17","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/jama.289.7.853","article-title":"Bivalirudin and provisional glycoprotein IIb\/IIIa blockade compared with heparin and planned glycoprotein IIb\/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial","volume":"289","author":"Lincoff","year":"2003","journal-title":"JAMA"},{"issue":"10366","key":"10.1016\/j.jscai.2025.103790_bib18","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/S0140-6736(22)01999-7","article-title":"Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial","volume":"400","author":"Li","year":"2022","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jscai.2025.103790_bib19","first-page":"226","volume":"2","author":"Liang","year":"2022","journal-title":"Cardiol Discov"},{"issue":"17","key":"10.1016\/j.jscai.2025.103790_bib20","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.jscai.2025.103790_bib21","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1161\/CIRCULATIONAHA.108.827162","article-title":"Incidence and prognostic significance of thrombocytopenia developed during acute coronary syndrome in contemporary clinical practice","volume":"119","author":"Wang","year":"2009","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.jscai.2025.103790_bib22","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jscai.2025.103790_bib23","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.114.002044","article-title":"Activated clotting time and outcomes during percutaneous coronary intervention for non-ST-segment-elevation myocardial infarction: insights from the FUTURA\/OASIS-8 trial","volume":"8","author":"Ducrocq","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.jscai.2025.103790_bib24","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.amjcard.2004.05.068","article-title":"Value of monitoring activated clotting time when bivalirudin is used as the sole anticoagulation agent for percutaneous coronary intervention","volume":"94","author":"Cheneau","year":"2004","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.jscai.2025.103790_bib25","first-page":"250","article-title":"Evaluation of bivalirudin hyper- and hypo-ACT responses in the setting of percutaneous coronary intervention","volume":"25","author":"Weeks","year":"2013","journal-title":"J Invasive Cardiol"},{"issue":"3","key":"10.1016\/j.jscai.2025.103790_bib26","first-page":"179","article-title":"Bivalirudin in primary PCI: can its glory being restored?","volume":"1","author":"Li","year":"2021","journal-title":"Cardiol Discov"},{"issue":"18","key":"10.1016\/j.jscai.2025.103790_bib27","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.1182\/blood-2010-09-307751","article-title":"Heparin promotes platelet responsiveness by potentiating \u03b1IIb\u03b23-mediated outside-in signaling","volume":"117","author":"Gao","year":"2011","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jscai.2025.103790_bib28","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.amjcard.2007.02.106","article-title":"Comparison of platelet function and morphology in patients undergoing percutaneous coronary intervention receiving bivalirudin versus unfractionated heparin versus clopidogrel pretreatment and bivalirudin","volume":"100","author":"Anand","year":"2007","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.jscai.2025.103790_bib29","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/HPC.0000000000000185","article-title":"The association between modified intracoronary thrombus grade and cardiovascular risk factors and initial laboratory findings in patients undergoing primary percutaneous coronary intervention","volume":"18","author":"Nozari","year":"2019","journal-title":"Crit Pathw Cardiol"},{"issue":"2","key":"10.1016\/j.jscai.2025.103790_bib30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3390\/medicina58020143","article-title":"Systemic immune-inflammation index: a novel predictor of coronary thrombus burden in patients with non-ST acute coronary syndrome","volume":"58","author":"\u00d6zkan","year":"2022","journal-title":"Medicina (Kaunas)"},{"issue":"12","key":"10.1016\/j.jscai.2025.103790_bib31","article-title":"Risk assessment of patients after ST-segment elevation myocardial infarction by Killip classification: an institutional experience","volume":"12","author":"Hashmi","year":"2020","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.jscai.2025.103790_bib32","first-page":"107","article-title":"Validation of the Killip-Kimball classification and late mortality after acute myocardial infarction","volume":"103","author":"Mello","year":"2014","journal-title":"Arq Bras Cardiol"},{"issue":"11","key":"10.1016\/j.jscai.2025.103790_bib33","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.amjcard.2005.01.071","article-title":"Comparison of enoxaparin versus heparin during elective percutaneous coronary intervention performed with either eptifibatide or tirofiban (the ACTION Trial)","volume":"95","author":"Madan","year":"2005","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.jscai.2025.103790_bib34","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3909\/ricm0778","article-title":"Heparin: physiology, pharmacology, and clinical application","volume":"16","author":"Lee","year":"2015","journal-title":"Rev Cardiovasc Med"},{"issue":"4","key":"10.1016\/j.jscai.2025.103790_bib35","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1527-3466.2005.tb00177.x","article-title":"Bivalirudin: pharmacology and clinical applications","volume":"23","author":"Shammas","year":"2005","journal-title":"Cardiovasc Drug Rev"},{"issue":"1","key":"10.1016\/j.jscai.2025.103790_bib36","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0149-2918(02)85004-4","article-title":"Bivalirudin: a direct thrombin inhibitor","volume":"24","author":"Gladwell","year":"2002","journal-title":"Clin Ther"},{"issue":"12","key":"10.1016\/j.jscai.2025.103790_bib37","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1586\/erc.10.158","article-title":"Bivalirudin: a review of the pharmacology and clinical application","volume":"8","author":"Van De Car","year":"2010","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"4","key":"10.1016\/j.jscai.2025.103790_bib38","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/0735-1097(94)90636-X","article-title":"Comparison of Hemochron and HemoTec activated coagulation time target values during percutaneous transluminal coronary angioplasty","volume":"23","author":"Avenda\u00f1o","year":"1994","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of the Society for Cardiovascular Angiography &amp; Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772930325012323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772930325012323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T00:30:57Z","timestamp":1762648257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772930325012323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2772930325012323"],"URL":"https:\/\/doi.org\/10.1016\/j.jscai.2025.103790","relation":{},"ISSN":["2772-9303"],"issn-type":[{"value":"2772-9303","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Pre-PCI Activated Clotting Time on Outcomes of Bivalirudin Versus Heparin During Primary PCI","name":"articletitle","label":"Article Title"},{"value":"Journal of the Society for Cardiovascular Angiography & Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jscai.2025.103790","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of the Society for Cardiovascular Angiography & Interventions Foundation.","name":"copyright","label":"Copyright"}],"article-number":"103790"}}